543 related articles for article (PubMed ID: 27009896)
1. Are current screening protocols for chronic hepatitis B virus infection adequate?
Mortensen E; Kamali A; Schirmer PL; Lucero-Obusan C; Winston CA; Oda G; Winters MA; Durfee J; Martinello RA; Davey VJ; Holodniy M
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):159-67. PubMed ID: 27009896
[TBL] [Abstract][Full Text] [Related]
2. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
4. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of occult hepatitis B virus infection in chronic haemodialysis and kidney transplant patients.
Muche M; Berg T; Rimpler S; Staedtler A; Böhm S; Nickel P; Baid-Agrawal S
Liver Int; 2019 Feb; 39(2):263-270. PubMed ID: 30171739
[TBL] [Abstract][Full Text] [Related]
7. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
8. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
[TBL] [Abstract][Full Text] [Related]
9. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
10. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
Kang SY; Kim MH; Lee WI
Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
[TBL] [Abstract][Full Text] [Related]
12. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
14. Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature.
Hedayati-Moghaddam MR; Tehranian F; Mosavat A; Miri R; Ahmadi Ghezeldasht S
Arch Iran Med; 2024 Jun; 27(6):305-312. PubMed ID: 38855800
[TBL] [Abstract][Full Text] [Related]
15. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
Vargas JI; Jensen D; Sarmiento V; Peirano F; Acuña P; Fuster F; Soto S; Ahumada R; Huilcaman M; Bruna M; Jensen W; Fuster F
J Med Virol; 2016 Apr; 88(4):639-46. PubMed ID: 26381185
[TBL] [Abstract][Full Text] [Related]
16. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
[TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
Varaklioti A; Kouramba A; Ioannidou P; Katsarou O
Infect Genet Evol; 2017 Oct; 54():397-401. PubMed ID: 28705716
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O
Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
20. Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers.
Tandoi F; Caviglia GP; Pittaluga F; Abate ML; Smedile A; Romagnoli R; Salizzoni M
Dig Liver Dis; 2014 Nov; 46(11):1020-4. PubMed ID: 25201211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
